EUVIMEDEUVIMED entdecken
Crossref

Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study

Elizabeth A Mullen, Lindsay A Renfro, Peter F Ehrlich, Geetika Khanna, Eric J Gratias, Nicholas G Cost, Lauren N Parsons, Paul E Grundy, Conrad V Fernandez, James I Geller, Jeffrey S Dome, AREN03B2 study committee

Pediatric Blood & Cancer · 2026-10 · 73 (10)

DOI: 10.1002/1545-5017.70515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 04.08.2026. Verfasst von Elizabeth A Mullen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Kidney Neoplasms, Wilms Tumor, Lung Neoplasms. Die Arbeit nennt 22 Literaturangaben. Gefördert von: St. Baldrick's Foundation, NCI NIH HHS, Solder True Life Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Children's Oncology Group (COG) AREN03B2 Renal Tumor Biology/Classification Study undertook real‐time central reviews to facilitate accurate diagnosis, staging, and risk stratification for enrollment on therapeutic trials. This study assessed concordance between central and institutional reviews to inform future clinical trials and real‐world practice. Procedure Eligible patients who enrolled on AREN03B2 from 2006 to 2019 were included. COG experts performed real‐time central radiology review to assess lung metastasis and bilateral renal lesions, pathology review for histology and pathological stage, and surgery review of local staging. An initial risk assignment (IRA) was made based on these reviews. Concordance between institutional and central reviews was measured using raw rates of agreement (%) and Cohen's kappa coefficient for inter‐rater reliability.

Results

6311 patients were included. Raw rate of agreement between institutional and central pathological diagnosis was 91.1% (Cohen's kappa: 0.79 [95% CI: 0.78–0.81]). Among patients with unilateral tumors, only 181/269 (67%) with diffuse anaplastic Wilms tumor were correctly identified by local institutions. Raw rate of agreement between assessments of computed tomography (CT) scans for lung nodules was 96.1% (Cohen's kappa: 0.88 [95% CI: 0.86–0.89]). Raw rate of agreement between surgical reviews for local stage was 90% (Cohen's kappa: 0.84 [95% CI: 0.83–0.85]). Raw rate of agreement between calculated institutional and central IRA was 87% (Cohen's kappa: 0.84 [95% CI: 0.83–0.85]).

Conclusions

Central reviews were highly concordant with institutional assessments, though lack of recognition of anaplastic histology by institutional pathologists was notable. Institutions should consider expert pathology consultation in the absence of a clinical trial with integrated central review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsWilms TumorLung NeoplasmsHumansChildFemaleMaleChild, PreschoolNeoplasm StagingInfantPrognosisTomography, X-Ray Computed

Stichwörter der Autor:innen

Wilms tumorbiologyclassificationrenal tumorrisk stratification

Autor:innen und Institutionen

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Biostatistics, University of Southern California, Los Angeles, California, USA.
  • Section of Pediatric Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Children's Healthcare of Atlanta and the Department of Radiology & Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
  • UnitedHealthcare Clinical Services, Minnetonka, Minnesota, USA.
  • Department of Surgery, Division of Urology, University of Colorado School of Medicine and The Surgical Oncology Program at the Children's Hospital of Colorado, Aurora, Colorado, USA.

Förderung

  • St. Baldrick's Foundation
  • NCI NIH HHS
  • Solder True Life Foundation
  • National Cancer Institute

Zitieren

APA

Mullen, E. A., Renfro, L. A., Ehrlich, P. F., Khanna, G., Gratias, E. J., Cost, N. G., Parsons, L. N., Grundy, P. E., Fernandez, C. V., Geller, J. I., Dome, J. S., & AREN03B2 study committee (2026). Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70515

Vancouver

Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, et al. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70515

BibTeX
@article{Mullen2026,
  author = {Mullen, Elizabeth A and Renfro, Lindsay A and Ehrlich, Peter F and Khanna, Geetika and Gratias, Eric J and Cost, Nicholas G and Parsons, Lauren N and Grundy, Paul E and Fernandez, Conrad V and Geller, James I and Dome, Jeffrey S and AREN03B2 study committee, AREN03B2 study committee},
  title = {Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {10},
  doi = {10.1002/1545-5017.70515}
}
Kostenlos starten →